Tandem’s chief commercial officer to resign ahead of insulin pump rollout

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

Tandem Diabetes Care’s chief commercial officer Brian Hansen will resign from his role in December, according to a Friday securities filing.
Hansen signed a separation agreement with the company that allows him to continue receiving his salary and bonuses until June 2024, effectively serving as a severance package.
The departure is happening at the same time that Tandem is starting to roll out its new Mobi device, a miniaturized durable insulin pump.

Dive Insight:

Hansen has worked for Tandem since 2016, according to his LinkedIn account. Starting Dec. 29, he will no longer be chief commercial officer, but will continue to be a salaried employee on paid administrative leave through June, per the agreement.

Tandem hasn’t yet set out plans for hiring a new chief commercial officer. Its Mobi insulin pump received 510(k) clearance in June. The company plans to start an early access program for the device in the fourth quarter, and move forward with a commercial launch in early 2024, CEO John Sheridan said in an early August earnings call.

Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 30, 2024

Promising new drug target for triple-negative breast cancer identified

Improving treatments for triple-negative breast cancer (TNBC), an aggressive tumor with very poor prognosis and limited therapeutic targets, has been challenging.

October 31, 2023

Body temperature fluctuations tied to depression severity

Study links higher body temperatures and reduced temperature fluctuations with increased depression severity, suggesting temperature regulation as a potential treatment target.

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.